Obagi’s expansion into injectables is one of the biggest moves in aesthetics right now.

For decades, Obagi has been one of the most recognizable names in medical-grade skincare. Now, the company is making a major expansion into injectables, and the industry is paying attention.

In this episode of The Dr. Randi Show, Dr. Randi sits down with Drew Fine of Obagi Medical for a conversation about the brand’s entry into HA fillers, the changing face of aesthetics, and why patients are demanding a dramatically different approach to aging than they were even a few years ago.

This conversation goes beyond products. It’s about where the industry is headed next.

Inside the episode:

• Why the era of overfilled faces is losing momentum

• Why skin quality has become the new luxury in aesthetics

• The real reason brands are racing toward longevity and regenerative beauty

• Why “undetectable” injectables are becoming the goal

• The skincare categories suddenly exploding in growth, including scalp health, lashes, brows, and NAD+ innovation

• Why the future of aesthetics may belong to brands that can connect skincare, injectables, wellness, and aging together

Drew also shares why Obagi believes this expansion marks the beginning of a much larger evolution for the brand and the industry overall.

---

Listeners should not rely on any content from this podcast as a substitute for professional medical advice. Always consult a licensed physician or qualified healthcare provider regarding any medical concerns, treatments, or decisions. This podcast does not endorse or guarantee the safety or efficacy of any products, procedures, or services discussed.

This podcast is not intended for individuals under the age of 18.

Neither the host nor any guests assume liability for any loss, injury, or damage resulting from the use or application of the information discussed on this show.